Vitamin D3 treatment of tumor bearers can stimulate immune competence and reduce tumor growth when treatment coincides with a heightened presence of natural suppressor cells

This publication has 34 references indexed in Scilit:

• Ineffective immune enhancement by IL-12 in tumor-bearing mice whose immune depression is mediated by suppressive granulocyte-macrophage progenitor cells
  Cancer Letters, 1995
• THE INHIBITORY EFFECT OF CYCLOPHOSPHAMIDE-INDUCED MAC-1+ NATURAL SUPPRESSOR CELLS ON IL-2 AND IL-4 UTILIZATION IN MLR
  Transplantation, 1994
• Phenotypic analysis of nylon-wool-adherent suppressor cells that inhibit the effector process of tumor cell lysis by lymphokine-activated killer cells in patients with advanced gastric carcinoma
  Zeitschrift für Krebsforschung und Klinische Onkologie, 1994
• Tumour Growth Causes Suppression of Autoreactive T-Cell Proliferation by Disrupting Macrophage Responsiveness to Interferon-gamma
  Scandinavian Journal of Immunology, 1994
• In vitro modulation of proliferation and phenotype of resting and mitogen-stimulated bovine mononuclear leukocytes by 1,25-dihydroxyvitamin D3
  Veterinary Immunology and Immunopathology, 1993
• 1,25‐Dihydroxyvitamin D₃ increases type 1 interleukin‐1 receptor expression in a murine T cell line
  Journal of Cellular Biochemistry, 1993
• 1,25-Dihydroxyvitamin D3 prevents insulitis in NOD mice
  Diabetes, 1992
• Production of granulocyte-macrophage colony-stimulating factor in two patients with lung cancer, leukocytosis, and eosinophilia
  Cancer, 1992
• Enhancement of cytotoxic T lymphocyte growth from spleens of P815-tumor-bearing host mice with mafosfamide
  Cancer Immunology, Immunotherapy, 1992
• Effects of cytokines on in vitro colony formation of primary human tumour specimens
  European Journal of Cancer and Clinical Oncology, 1990